{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:08:55Z","timestamp":1786975735702,"version":"build-2736575974"},"reference-count":20,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi251413-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Household contacts of patients with invasive group A streptococcus (iGAS) disease have an increased risk of iGAS. In the Netherlands, the iGAS public health policy was changed in January 2023, offering antibiotic prophylaxis to household contacts of all patients with iGAS rather than only those presenting with necrotizing fasciitis or streptococcal toxic shock syndrome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251413-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To estimate risk of iGAS in the general population and among household and other contacts of primary patients with iGAS, before and after the policy change.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251413-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This nationwide, population-based, open cohort study, linked population registry data with iGAS laboratory data for the study period (April 2022 to December 2024). The study population consisted of all persons included in the Dutch population registry at any time during the study period. The case definition was an iGAS isolate submitted to the Netherlands Reference Laboratory for Bacterial Meningitis, with disease onset in the study period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251413-7\">\n                    <jats:title>Exposure<\/jats:title>\n                    <jats:p>For contacts of primary patients with iGAS, exposure risk period was defined as the 30 days after culture date of the index patient. Exposure under the new policy was defined as all person-time after January 20, 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251413-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Incidence rate ratios (IRR) of iGAS during the 30-day risk period compared with unexposed person-time were estimated. Secondary attack rates among household contacts were estimated with an odds ratio (OR) to compare attack rates before and after the policy change. Estimates were adjusted for age group, sex, household socioeconomic status, and year quarter.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251413-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 19\u202f006\u202f247 persons (9\u202f467\u202f251 male [49.8%]; 6\u202f308\u202f794 [33.2%] aged 20-45 years) contributed 51\u202f067\u202f977 person-years to the analysis. A total of 3644 iGAS isolates from 3630 unique persons were included, of which 14 were household secondary cases. The IRR for household contacts during the risk period was 235.25 (95% CI, 94.35-586.59) before and 74.00 (95% CI, 35.17-155.71) after the policy change, compared with unexposed person-time. The secondary attack rate among household contacts was 0.219% (7 individuals) before and 0.047% (7 individuals) after the policy change (adjusted OR, 0.17; 95% CI, 0.03-0.83).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi251413-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this nationwide cohort study, there was a reduction in secondary iGAS risk among household contacts after implementation of an expanded antibiotic prophylaxis policy, which suggests that antibiotic prophylaxis for household contacts of patients with iGAS prevents secondary iGAS infection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.53168","type":"journal-article","created":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:00:42Z","timestamp":1767888042000},"page":"e2553168","source":"Crossref","is-referenced-by-count":3,"title":["Risk of Household Secondary Invasive Group A Streptococcal Infections After a Prophylaxis Policy Change"],"prefix":"10.1001","volume":"9","author":[{"given":"Brechje","family":"de Gier","sequence":"first","affiliation":[{"name":"Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart J. M.","family":"Vlaminckx","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"van Roon","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam J.","family":"Knol","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margreet J. M.","family":"te Wierik","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan W.","family":"Notermans","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester E.","family":"de Melker","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina M.","family":"van Sorge","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Center location AMC, University of Amsterdam, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands"},{"name":"Netherlands Reference Laboratory for Bacterial Meningitis, Amsterdam University Medical Center location AMC, Amsterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,1,8]]},"reference":[{"issue":"4","key":"zoi251413r1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2025.106468","article-title":"Antibiotic chemoprophylaxis for close contacts of invasive group A streptococcus in community settings: evidence review.","volume":"90","author":"Watts","year":"2025","journal-title":"J Infect"},{"issue":"7","key":"zoi251413r2","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1093\/cid\/ciz716","article-title":"Evaluating household transmission of invasive group A streptococcus disease in the United States using population-based surveillance data, 2013-2016.","volume":"70","author":"Adebanjo","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"19","key":"zoi251413r3","doi-asserted-by":"publisher","first-page":"30532","DOI":"10.2807\/1560-7917.ES.2017.22.19.30532","article-title":"Household transmission of invasive group A Streptococcus infections in England: a population-based study, 2009, 2011 to 2013.","volume":"22","author":"Mearkle","year":"2017","journal-title":"Euro Surveill"},{"issue":"1","key":"zoi251413r4","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2023.28.1.2200941","article-title":"Increase in invasive group A streptococcal (Streptococcus pyogenes) infections (iGAS) in young children in the Netherlands, 2022.","volume":"28","author":"de Gier","year":"2023","journal-title":"Euro Surveill"},{"issue":"10","key":"zoi251413r5","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00766-24","article-title":"Nationwide upsurge in invasive disease in the context of longitudinal surveillance of carriage and invasive Streptococcus pyogenes 2009-2023, the Netherlands: a molecular epidemiological study.","volume":"62","author":"R\u00fcmke","year":"2024","journal-title":"J Clin Microbiol"},{"issue":"2","key":"zoi251413r6","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3201\/eid3102.240880","article-title":"Streptococcus pyogenes emm Type 3.93 emergence, the Netherlands and England.","volume":"31","author":"Davies","year":"2025","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"zoi251413r14","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/cid\/ciae524","article-title":"Choosing wisely: effectiveness and safety of antibiotic prophylaxis in close contacts of invasive group A streptococci infection.","volume":"80","author":"Birck","year":"2025","journal-title":"Clin Infect Dis"},{"issue":"8","key":"zoi251413r15","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac244","article-title":"Effectiveness and safety of antibiotic prophylaxis for persons exposed to cases of invasive group a streptococcal disease: a systematic review.","volume":"9","author":"Khan","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"17","key":"zoi251413r16","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1001\/jama.2025.0910","article-title":"Invasive group A streptococcal infections in 10 US states.","volume":"333","author":"Gregory","year":"2025","journal-title":"JAMA"},{"issue":"20","key":"zoi251413r17","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2024.29.20.2400242","article-title":"Increase in invasive group A streptococcal infections (iGAS) in children and older adults, Norway, 2022 to 2024.","volume":"29","author":"Valcarcel Salamanca","year":"2024","journal-title":"Euro Surveill"},{"issue":"2","key":"zoi251413r18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S2352-4642(23)00295-X","article-title":"Invasive group A streptococcal infections in children and adolescents in Denmark during 2022-23 compared with 2016-17 to 2021-22: a nationwide, multicentre, population-based cohort study.","volume":"8","author":"Nygaard","year":"2024","journal-title":"Lancet Child Adolesc Health"},{"issue":"11","key":"zoi251413r19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2024.102545","article-title":"Post-pandemic increase in invasive group A strep infections in New Zealand.","volume":"17","author":"Ammar","year":"2024","journal-title":"J Infect Public Health"},{"issue":"5","key":"zoi251413r20","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s10096-023-04568-y","article-title":"Incidence and clinical and microbiological features of invasive and probable invasive streptococcal group A infections in children and adults in the Brussels\u2014capital region, 2005-2020.","volume":"42","author":"Zangarini","year":"2023","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"zoi251413r13","author":"Mujakovic"},{"key":"zoi251413r7","unstructured":"de Gier? B, te Wierik? M, Mujakovic? S, Notermans? D, de Melker? H, van Sorge? N. Invasive group A Streptococcal infections-increase and response 2022-2023.? Netherlands J of Med Microbiol. 2023;(4):145-150"},{"key":"zoi251413r8","unstructured":"Rijksinstituut voor Volksgezondheid en Milieu. LCI-richtlijn groep A-streptokokkeninfectie. Published December 8, 2023. Accessed November 25, 2025. https:\/\/lci.rivm.nl\/richtlijnen\/groep-streptokokkeninfectie."},{"key":"zoi251413r9","unstructured":"Statistics Netherlands (CBS). Colleganetwerktab: collegarelaties. Published April 30, 2025. Accessed November 25, 2025. https:\/\/www.cbs.nl\/nl-nl\/onze-diensten\/maatwerk-en-microdata\/microdata-zelf-onderzoek-doen\/microdatabestanden\/colleganetwerktab-collegarelaties"},{"key":"zoi251413r10","unstructured":"Statistics Netherlands (CBS). Burennetwerktab: buren- en buurtgenotenrelaties. Published April 30, 2025. Accessed November 25, 2025. https:\/\/www.cbs.nl\/nl-nl\/onze-diensten\/maatwerk-en-microdata\/microdata-zelf-onderzoek-doen\/microdatabestanden\/burennetwerktab-buren-en-buurtgenotenrelaties"},{"key":"zoi251413r11","unstructured":"Statistics Netherlands (CBS). Familienetwerktab: familierelaties. Published April 30, 2025. Accessed November 25, 2025. https:\/\/www.cbs.nl\/nl-nl\/onze-diensten\/maatwerk-en-microdata\/microdata-zelf-onderzoek-doen\/microdatabestanden\/familienetwerktab-familierelaties"},{"key":"zoi251413r12","unstructured":"Statistics Netherlands (CBS). Klasgenotennetwerktab: klasgenotenrelaties. Published April 30, 2025. Accessed November 25, 2025. https:\/\/www.cbs.nl\/nl-nl\/onze-diensten\/maatwerk-en-microdata\/microdata-zelf-onderzoek-doen\/microdatabestanden\/klasgenotennetwerktab-klasgenotenrelaties"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2843535\/de_gier_2026_oi_251413_1767025236.17242.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:00:42Z","timestamp":1767888042000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2843535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,8]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.53168","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,8]]}}}